Alercell
Alercell Inc
Alercell is developing blood-based epigenetic surveillance designed to detect pre-leukemic DNA methylation change before diagnosis. Built on 199,000+ patient records (EMR). AI epigenetic diagnostics.
alercell.com · Bozeman, Us, MT
Funding event
The round itself, as filedInferred stagePre-seed
Sold of offered$35K of $1.5M
Filed2026-10-19
Days since filing25
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- Yes
- Date of first sale
- 2026-10-12
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Frederic George-Etienne ScheerExecutive Officer
Health flags
Three flags, each with the raw inputs behind it · as of 2026-11-13UndersubscribedNot flagged$35K of $1.5M sold1.1 months since first sale
Prior raiseNot flaggedPrior raise not known—
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-10-210
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
Also raised in Health & bio
Same sector, 28 days to 2026-11-15OrcosaSeries A · $6.0M of $11.5M · Ewing, NJQuietChronicleBioPre-seed · $250K of $1.0M · Menlo Park, CAQuiet
103 rounds in Health & bio in the 28 days to 2026-11-12, against 122 in the 28 days before.